What is the current Europe Cancer Biomarkers Market size?

The Europe Cancer Biomarkers Market is projected to register a CAGR of 11.60% during the forecast period (2024-2029) Read More

Who are the key players in Europe Cancer Biomarkers Market?

Abbott Laboratories Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Thermo Fisher Scientific and Biomerieux are the major companies operating in the Europe Cancer Biomarkers Market. Read More

What years does this Europe Cancer Biomarkers Market cover?

The report covers the Europe Cancer Biomarkers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Cancer Biomarkers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Cancer Biomarkers Market - Share, Size & Industry Analysis

Europe Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Cancer Biomarker Market is Segmented by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases), Type (Protein Biomarkers, Genetic Biomarkers, and Other Types), Profiling Technology (OMICS Technology, Imaging Technology, Immunoassays, and Cytogenetics). The report offers the value (in USD million) for the above segments.

Europe Cancer Biomarkers Industry Overview

The European cancer biomarkers market is highly competitive and consists of a few major players. Some companies currently dominating the market include Abbott Laboratories Inc., Agilent Technologies, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific. Furthermore, some of the major market players, such as Novartis and Gilead in cancer therapy, are from Europe, one of the factors boosting the R&D activities in the region.